JOSD1 Human

Josephin Domain Containing 1 Human Recombinant
Cat. No.
BT17447
Source
Escherichia Coli.
Synonyms
Josephin-1, Josephin domain-containing 1, JOSD1, JSPH1, KIAA0063, dJ508I15.2.
Appearance
Sterile Filtered colorless solution.
Purity
Greater than 90.0% as determined by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

JOSD1 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 225 amino acids (1-202 a.a.) and having a molecular mass of 25.6kDa.
JOSD1 is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

Product Specs

Introduction
Josephin-1 (JOSD1) exhibits minimal protease activity towards poly-ubiquitin chains in laboratory settings. It acts as a deubiquitinating enzyme. The ubiquitin-binding sites within the Josephin domain contribute to the binding and cleavage of ubiquitin chains.
Description
Recombinant JOSD1 Human, produced in E. coli, is a single, non-glycosylated polypeptide chain consisting of 225 amino acids (specifically, amino acids 1 to 202). It has a molecular weight of 25.6 kDa. A 23 amino acid His-tag is fused to the N-terminus of JOSD1. Purification is achieved using proprietary chromatographic methods.
Physical Appearance
A clear, sterile-filtered solution.
Formulation
The JOSD1 protein solution has a concentration of 0.5 mg/ml. It is prepared in a buffer containing 20 mM Tris-HCl (pH 8.0), 0.2 M NaCl, 40% glycerol, 5 mM DTT, and 2 mM EDTA.
Stability
For short-term storage (2-4 weeks), the product can be stored at 4°C. For extended storage, freeze the product at -20°C. The addition of a carrier protein like 0.1% HSA or BSA is recommended for long-term storage. Repeated freezing and thawing should be avoided.
Purity
Purity exceeds 90.0%, as determined by SDS-PAGE analysis.
Synonyms
Josephin-1, Josephin domain-containing 1, JOSD1, JSPH1, KIAA0063, dJ508I15.2.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MGSMSCVPWK GDKAKSESLE LPQAAPPQIY HEKQRRELCA LHALNNVFQD SNAFTRDTLQ EIFQRLSPNT MVTPHKKSML GNGNYDVNVI MAALQTKGYE AVWWDKRRDV GVIALTNVMG FIMNLPSSLC WGPLKLPLKR QHWICVREVG GAYYNLDSKL KMPEWIGGES ELRKFLKHHL RGKNCELLLV VPEEVEAHQS WRTDV.

Product Science Overview

Introduction

Josephin Domain Containing 1 (JOSD1) is a protein encoded by the JOSD1 gene in humans. This protein is characterized by the presence of a Josephin domain, a type of cysteine protease domain that plays a crucial role in the deubiquitination process. Deubiquitination is the removal of ubiquitin from proteins, a process essential for various cellular functions, including protein degradation, signal transduction, and cell cycle regulation .

Structure and Function

JOSD1 is a protein coding gene that produces a polypeptide chain containing 225 amino acids with a molecular mass of approximately 25.6 kDa . The protein is often produced in recombinant form with an N-terminal His-tag to facilitate purification and study. The Josephin domain within JOSD1 is responsible for its deubiquitinase activity, which allows it to cleave ubiquitin from other proteins .

Biological Significance

JOSD1 has been implicated in various cellular processes. It is known to deubiquitinate monoubiquitinated probes in vitro and cleave both ‘Lys-63’-linked and ‘Lys-48’-linked poly-ubiquitin chains . This activity suggests that JOSD1 may play a role in regulating protein stability and function. Additionally, JOSD1 has been shown to increase macropinocytosis and suppress clathrin- and caveolae-mediated endocytosis, thereby enhancing membrane dynamics and cell motility independently of its catalytic activity .

Clinical Relevance

Mutations or dysregulation of JOSD1 have been associated with various diseases, including diabetic retinopathy and microvascular complications of diabetes . The protein’s role in deubiquitination and cellular dynamics makes it a potential target for therapeutic interventions in these conditions.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.